Avantor, Inc. (AVTR)
Largest Insider Buys in Sector
AVTR Stock Price History Chart
AVTR Stock Performance
About Avantor, Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial …
Insider Activity of Avantor, Inc.
Over the last 12 months, insiders at Avantor, Inc. have bought $0 and sold $1.05M worth of Avantor, Inc. stock.
On average, over the past 5 years, insiders at Avantor, Inc. have bought $544,479 and sold $1.24B worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,000 shares for transaction amount of $314,250 was made by Stubblefield Michael (CEO) on 2022‑11‑16.
List of Insider Buy and Sell Transactions, Avantor, Inc.
| 2024-09-05 | Sale | SVP & Chief Accounting Officer | 3,525 0.0005% | $25.06 | $88,337 | -3.28% | ||
| 2024-07-31 | Sale | EVP, AMEA | 100 <0.0001% | $28.00 | $2,800 | -5.36% | ||
| 2024-07-30 | Sale | EVP, AMEA | 10,000 0.0014% | $27.00 | $270,000 | -1.85% | ||
| 2024-03-08 | Sale | SVP & Chief Accounting Officer | 3,685 0.0005% | $25.63 | $94,447 | -2.81% | ||
| 2024-02-29 | Sale | EVP Sales, Customer Excellence | 4,910 0.0007% | $24.52 | $120,393 | +1.26% | ||
| 2024-02-29 | Sale | EVP, AMEA | 13,074 0.0019% | $24.53 | $320,705 | +1.26% | ||
| 2024-02-27 | Sale | EVP Sales, Customer Excellence | 6,203 0.0009% | $24.49 | $151,911 | +2.21% | ||
| 2023-09-07 | Sale | SVP & Chief Accounting Officer | 7,577 0.0011% | $20.64 | $156,389 | +11.64% | ||
| 2023-08-25 | Sale | EVP, Americas and Europe | 25,000 0.0036% | $21.47 | $536,750 | +4.92% | ||
| 2023-04-11 | Sale | EVP, AMEA | 1,498 0.0002% | $21.18 | $31,728 | -2.41% | ||
| 2023-03-03 | Sale | EVP, Biopharma Production | 3,914 0.0006% | $25.00 | $97,850 | -16.53% | ||
| 2023-02-28 | Sale | EVP, AMEA | 2,324 0.0003% | $24.32 | $56,520 | -14.03% | ||
| 2023-02-27 | Sale | EVP, Biopharma Production | 3,059 0.0005% | $25.00 | $76,475 | -13.86% | ||
| 2023-02-23 | Sale | EVP, AMEA | 3,078 0.0004% | $24.24 | $74,611 | -14.80% | ||
| 2023-02-22 | Sale | EVP, AMEA | 19,160 0.0028% | $24.12 | $462,139 | -13.25% | ||
| 2023-02-02 | Sale | EVP, Biopharma Production | 11,339 0.0017% | $25.06 | $284,155 | -15.80% | ||
| 2022-11-16 | CEO | 15,000 0.0023% | $20.95 | $314,250 | +1.75% | |||
| 2022-11-16 | EVP & CFO | 12,500 0.0019% | $20.71 | $258,850 | +1.75% | |||
| 2022-05-23 | Sale | EVP, Americas & Europe | 39,000 0.0061% | $31.61 | $1.23M | -30.23% | ||
| 2022-05-20 | Sale | EVP, Biopharma Production | 19,603 0.003% | $31.27 | $612,986 | -29.16% |
Insider Historical Profitability
| Connolly Thomas | 58881710 8.6513% | $20.28 | 7 | 8 | +6.56% | |
| GOLDMAN SACHS & CO. LLC | 43483708 6.3889% | $20.28 | 17 | 19 | +37.47% | |
| Natauri Jo | director | 557656 0.0819% | $20.28 | 18 | 20 | +35.53% |
| Stubblefield Michael | CEO | 429500 0.0631% | $20.28 | 1 | 6 | +1.75% |
| Szlosek Thomas A | EVP & CFO | 35668 0.0052% | $20.28 | 1 | 0 | +1.75% |
Institutional Investor Ownership
| The Vanguard Group | $1.65B | 9.49 | 64.45M | -1.37% | -$22.82M | 0.03 | |
| Dodge & Cox | $1.63B | 9.38 | 63.68M | +4.06% | +$63.52M | 0.95 | |
| T Rowe Price Investment Management Inc | $1.31B | 7.52 | 51.1M | -2.97% | -$40.02M | 0.8 | |
| BlackRock | $1.09B | 6.3 | 42.76M | -6.73% | -$78.89M | 0.02 | |
| Boston Partners | $729.3M | 4.21 | 28.56M | +2.23% | +$15.94M | 0.87 |